NSAIDs Stent Study
NCT03638999
- Conditions
- Ureteral Stent Placement, Kidney Stone
- Interventions
- Ketorolac Trometamol 30Mg/1mL Injection, Normal saline
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2027
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
Source: ClinicalTrials.gov public record
Updated Dec 21, 2025 · Synced May 21, 2026, 9:51 PM EDT